Print this page

BREAKING NEWS! HIP UPDATE

This Firm continues to be consulted by persons affected by the consequences of the DePuy Hip Replacement saga. Yet, it is now becoming apparent that many of the people who indicate ongoing pain and suffering associated with their hip implant have not been called by the HSE for a review.

As it has been reported that DePuy ASR™ metal-on-metal hip replacements have been found to have a high failure rate and to cause high levels of metal ion release into patients who have been fitted with the device, such a failure for a proactive review process is all the more surprising.

In addition, patients are anxious to ascertain, as soon as is practicable, as to whether they have suffered consequences arising from a potentially defective metal-on-metal hip replacement.

Although the Health Service Executive had written to all Hospital Orthopaedic Units on 27th August 2010, advising them to remove from stock the DePuy ASR™ XL Acetabular System, no further correspondence appears to have emanated from the HSE.

In those circumstances, patients who contact this Firm are indicating:

1.That they require, as a matter of priority, the necessary blood checks to be undertaken to ascertain as to whether microscopic metal particles around the implant are so present in their bloodstream.

2.That, in circumstances where such microscopic metal particles are found in relation to such blood tests, a further MRI Scan should be undertaken as a matter of priority.

There is a degree of urgency in relation to such an issue as patients are concerned in relation to their own welfare. In addition, they continue to suffer pain arising out of the problems associated with such a potentially defective hip device.

Also, it is noted that DePuy have neglected to clarify as to whether they are continuing to rely upon their precondition that patients must sign the consent form for the purposes of allowing the costs to be discharged by them of any hip revision procedure that occurs. In those circumstances, clarification is required from both the HSE and DePuy as to whether such a precondition will continue to be imposed upon patients who have suffered adverse effects associated with this hip device.

Raymond Bradley, Managing Partner of Malcomson Law on RTE News, click here to view.

If you have suffered harm or injury from a defective DePuy hip implant then please contact Malcomson Law on (01) 8744422 or complete an Online Enquiry Form.

This news section contains stories of interest from publicly available news sources. Where we are representing the clients referred to in the news material we will say so. Where we do not represent individuals or bodies mentioned or quoted, the inclusion of the news story in our news section is not intended nor should it be taken to imply that we act for the individual or body concerned.